Wealthcare Advisory Partners LLC Gsk PLC Transaction History

Wealthcare Advisory Partners LLC

$3.43 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $1,093 - $1,242	26 Added 0.55%	4,769 $208,000
Q1 2022 Apr 15, 2022	SELL	$40.23 - $47.74 $11,143 - $13,223	-277 Reduced 5.52%	4,743 $207,000
Q4 2021 Feb 11, 2022	BUY	$38.88 - $45.31 $195,177 - $227,456	5,020 New	5,020 $225,000
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $174,383 - $197,971	-4,775 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$34.27 - $40.01 $163,639 - $191,047	4,775 New	4,775 $170,000
Q2 2020 Jul 29, 2020	SELL	$37.87 - $43.58 $73,013 - $84,022	-1,928 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$32.47 - $48.83 $80,785 - $121,489	-2,488 Reduced 56.34%	1,928 $73,000
Q4 2019 Jan 29, 2020	BUY	$42.0 - $48.25 $13,314 - $15,295	317 Added 7.73%	4,416 $207,000
Q3 2019 Oct 17, 2019	SELL	$40.46 - $43.52 $17,681 - $19,018	-437 Reduced 9.63%	4,099 $175,000
Q2 2019 Jul 30, 2019	BUY	$39.4 - $42.7 $22,064 - $23,912	560 Added 14.08%	4,536 $182,000
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $1,697 - $1,878	-44 Reduced 1.09%	3,976 $166,000
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $9,412 - $10,629	249 Added 6.6%	4,020 $154,000
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $8,347 - $8,964	-210 Reduced 5.28%	3,771 $151,000
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $16,279 - $17,574	411 Added 11.51%	3,981 $160,000
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $57,707 - $64,039	1,595 Added 80.76%	3,570 $139,000
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $54,600 - $64,735	-1,545 Reduced 43.89%	1,975 $70,000
Q3 2017 Nov 15, 2017	BUY	$39.44 - $41.55 $132,163 - $139,234	3,351 Added 1982.84%	3,520 $143,000
Q2 2017 Aug 29, 2017	BUY	N/A	169	169 $7,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Account